Bayesian Capital Management’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,053
Closed -$288K 726
2020
Q3
$288K Sell
2,053
-15,900
-89% -$1.94M 0.07% 355
2020
Q2
$1.35M Sell
17,953
-2,900
-14% -$152K 0.3% 88
2020
Q1
$595K Buy
+20,853
New +$540K 0.13% 243

Bayesian Capital Management's LVGO Position: Q4 2020 in Review

Bayesian Capital Management sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 2,053 shares — an estimated $288K sold.

Bayesian Capital Management first reported a position in LVGO in Q1 2020 and held it in 3 quarters. The position peaked at $1.35M in Q2 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

  • Bayesian Capital Management reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Bayesian Capital Management sold 2,053 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $288K.
  • Bayesian Capital Management first reported a position in Livongo Health, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • Bayesian Capital Management's Livongo Health, Inc. Common Stock position peaked at $1.35M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Bayesian Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.